@prefix this: <http://purl.org/np/RA3C8xH7N-i_EOZXWuu_gJ2qwkE4nHBAbsMCc8PFTHcw0> .
@prefix sub: <http://purl.org/np/RA3C8xH7N-i_EOZXWuu_gJ2qwkE4nHBAbsMCc8PFTHcw0#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_12236> bl:category bl:Disease .
  
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_12236>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB01241>;
    a rdf:Statement;
    rdfs:label "\"1. Hepatic or severe renal dysfunction, including primary biliary cirrhosis. 2. Preexisting gallbladder disease (see  WARNINGS 3. Hypersensitivity to gemfibrozil. 4. Combination therapy of gemfibrozil with simvastatin (see  WARNINGS PRECAUTIONS 5. Combination therapy of gemfibrozil with repaglinide (see  PRECAUTIONS 6. Combination therapy of gemfibrozil with dasabuvir (see  PRECAUTIONS 7. Combination therapy of gemfibrozil with selexipag (see  PRECAUTIONS\"";
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation schema:MedicalContraindication .
  
  <https://identifiers.org/drugbank:DB01241> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "Eqn67ojrWo4MndkqsLmql+WEbn7y9EOOxtr1b/br2WgbGNnxK/+nTEhSYl90zpiB/BP7eHafH6ozLQA3CuBQMyCK8CBVHLuPUKob5I74OMknPgWOzFVIV6MCtNqp+gV3Q96xy+2XHy+faxDzft6D9WllofD1fBMaeOlYt/GpRpc=";
    npx:hasSignatureTarget this: .
  
  this: dct:created "2021-08-22T17:26:43.390+02:00"^^xsd:dateTime;
    dct:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}